Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Johnson & Johnson JNJ

Healthcare  —  Drug Manufacturers General
271.22 0.54 0.20% as of 25 Sep
Market cap
$652.8B
P/E
31.4×
S&P 500 Member Dividend Aristocrat Cash Flow Champion (3y) Revenue Champion (3y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Johnson & Johnson (JNJ) Book value per share

Johnson & Johnson's book value per share at the end of fiscal 2025 was 33.9×, up 14.1% from 29.7× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 35.3×. Over the past ten years it has ranged from 22.3× (fiscal 2018) to 33.9× (fiscal 2025) — the current reading is the highest in ten years. Johnson & Johnson ranks 3rd of 21 Drug Manufacturers General companies by book value per share.

Book value per share, annual

Annual

Period Book value per share Change
FY2025 33.9× 14.06%
FY2024 29.7× 9.40%
FY2023 27.1× (7.21%)
FY2022 29.3× 4.03%
FY2021 28.1× 17.01%
FY2020 24.0× 6.90%
FY2019 22.5× 0.90%
FY2018 22.3× (0.29%)
FY2017 22.3× (13.13%)
FY2016 25.7× 0.22%

Quarterly

Period Book value per share Change
Jun 2026 35.3× 4.72%
Mar 2026 33.7× (0.49%)
Dec 2025 33.9× 2.90%
Sep 2025 32.9× 0.94%
42 more quarters

Against its own ten years

Low 22.3× High 33.9×
Ten-year median 25.7×
Current reading's percentile 100

Book value per share against peers

Company Book value per share
LLY Eli Lilly and Company compare 38.0×
JNJ Johnson & Johnson 35.3×
AZN AstraZeneca PLC compare 32.5×
NVS Novartis AG compare 22.0×
AMGN Amgen Inc. compare 21.6×
MRK Merck & Co., Inc. compare 17.0×
PFE Pfizer Inc. compare 15.0×
GILD Gilead Sciences, Inc. compare 9.4×
ABBV AbbVie Inc. compare −3.3×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on JNJ